SUTINAT 25 28 CAPSULES BOTTLE

SUTINAT 25 28 CAPSULES BOTTLE Specification

Indication
Renal cell carcinoma, GIST

Salt Composition
Sunitinib Malate 25 mg

Dosage Form
Capsule

Feature
Targeted therapy; tyrosine kinase inhibitor

Ingredients
Sunitinib Malate, excipients

Application
Oral anticancer therapy

Physical Color/Texture
Yellow capsules

Fermentation Smell
Odorless

Storage Instructions
Store below 25C

Shelf Life
24 months

Prescription
Rx only

Packing
Bottle of 28

Strength
25 mg

Blister type
Opaque bottle

Route
Oral

Capsule count
28

Generic Name
Sunitinib Malate

SUTINAT 25 28 CAPSULES BOTTLE Trade Information

Minimum Order Quantity
1 Box

Supply Ability
5000 Boxes Per Month

Delivery Time
10 Days

About SUTINAT 25 28 CAPSULES BOTTLE

Experience the phenomenal efficacy of SUTINAT 25 28 CAPSULES BOTTLE, a targeted therapy featuring Sunitinib Malate 25 mg per capsule. Primarily indicated for renal cell carcinoma and GIST, this eminent oral anticancer agent is presented in a secure, opaque bottle of 28 yellow, odorless capsules. Known for its exceptional tyrosine kinase inhibition, SUTINAT 25 guarantees superior outcomes in cancer care. Limited stock available at a special deal-try now! Ideal for healthcare exporters, suppliers, traders, and wholesalers across India. Store below 25C for sustained potency.

Comprehensive Application and Features of SUTINAT 25 28 CAPSULES BOTTLE

SUTINAT 25 is specifically designed for oral administration, making it convenient for patients requiring long-term therapy for renal cell carcinoma and GIST. Its targeted action as a tyrosine kinase inhibitor exemplifies advanced medical innovation. The product contains high-purity Sunitinib Malate and excipients, engineered for exceptional performance. The yellow capsules are supplied in tamper-proof, opaque bottles, ensuring safe handling and optimum shelf stability.

Sample Availability, Certifications, and Efficient Transportation of SUTINAT 25

Samples of SUTINAT 25 28 CAPSULES BOTTLE are available for preliminary evaluation upon request. Certified to meet quality standards, this product is reliably handed over at the designated FOB port, guaranteeing seamless international transportation. Each batch is accompanied by necessary documentation, ensuring a smooth handover process for global exporters, distributors, and healthcare traders seeking premium oncology solutions.

FAQ's of SUTINAT 25 28 CAPSULES BOTTLE:

Q: How does SUTINAT 25 28 CAPSULES BOTTLE contribute to cancer therapy?

A: SUTINAT 25 contains Sunitinib Malate, which acts as a targeted tyrosine kinase inhibitor, helping to slow or stop the growth of cancer cells in conditions such as renal cell carcinoma and gastrointestinal stromal tumors (GIST).

Q: What is the appropriate way to use SUTINAT 25 capsules?

A: SUTINAT 25 capsules should be taken orally as prescribed by a healthcare professional. The dosage and schedule will depend on the patient's medical condition and treatment plan.

Q: Where can SUTINAT 25 28 CAPSULES BOTTLE be obtained?

A: SUTINAT 25 is available through licensed exporters, suppliers, traders, and wholesalers across India. It is distributed in secure, opaque bottles and is prescription-only.

Q: What is the process for obtaining a sample of SUTINAT 25?

A: Qualified healthcare professionals or authorized distributors can request a sample for evaluation, which will be handed over at the designated FOB port with all required certifications and documentation.

Q: Are there any special storage instructions for SUTINAT 25?

A: Yes, SUTINAT 25 should be stored below 25C in its original, opaque bottle to maintain its effectiveness and extend its shelf life of up to 24 months.

Q: What are the benefits of the opaque bottle packaging?

A: The opaque bottle ensures that the capsules are protected from light and contamination, preserving their quality and efficacy throughout the shelf life.

Tell us about your requirement